HHS owns patent rights to Remdesivir, and could control the price. Gilead charges $3100 per course; the cost of production is about $10. Might failure to do so be because the Gilead CEO bribed #MoscowMitch to block Senate action? https://t.co/8TgqXrXl24https://t.co/H3BJw8Ucc6— Real Fake P0TUS (@RF_P0TUS) July 6, 2020
Monday, July 6, 2020
HHS owns patent rights to Remdesivir, and could control the price. Gilead charges $3100 per course; the cost of production is about $10. Might failure to do so be because the Gilead CEO bribed #MoscowMitch to block Senate action?
